43 filings
8-K
ELTX
Elicio Therapeutics Inc.
5 Apr 24
Other Events
4:33pm
8-K
ELTX
Elicio Therapeutics Inc.
29 Mar 24
Results of Operations and Financial Condition
8:35am
8-K
ELTX
Elicio Therapeutics Inc.
18 Mar 24
Entry into a Material Definitive Agreement
8:05am
8-K
ELTX
Elicio Therapeutics Inc.
2 Feb 24
Departure of Directors or Certain Officers
8:51am
8-K
ELTX
Elicio Therapeutics Inc.
17 Jan 24
Other Events
8:35am
8-K
kvrti2dv4v1ywsizstw3
16 Jan 24
Other Events
7:59am
8-K
7agh91ogcqvq09l
9 Jan 24
Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutic’s AMPLIFY-201 Phase 1 Solid Tumor Study of ELI-002
8:11am
8-K
fclzn 3nt9
22 Dec 23
Entry into a Material Definitive Agreement
9:06am
8-K
m7yxl y7wj
9 Nov 23
Results of Operations and Financial Condition
4:41pm
8-K
khh1v253
3 Nov 23
Other Events
5:10pm
8-K
phdo2e5z
20 Oct 23
Departure of Directors or Certain Officers
7:58am
8-K
1fwlsegco1pz
12 Oct 23
Departure of Directors or Certain Officers
7:59am
8-K
9pkwtv8qhoo ipsg6
27 Sep 23
Other Events
5:41pm
8-K
a7sfln 45kxdxyj
7 Sep 23
Other Events
8:00am
8-K
tjzkc76549z9mgx
30 Aug 23
Departure of Directors or Certain Officers
4:33pm
8-K/A
765fjb6g0mqutodf8i
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
8-K
8nyjens38nh2 g42m6p
11 Aug 23
Elicio Therapeutics Reports Second Quarter 2023 Financial Results and Provides
11:42am
8-K
hu4nnkc1so18mtulh
5 Jun 23
Other Events
8:00am
8-K
faac0i72
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
npcnwa5imb0rcfxti
30 May 23
Other Events
4:39pm